Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-11-347997
Filing Date
2011-12-21
Accepted
2011-12-21 07:37:18
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d268585ds3.htm S-3 182898
2 OPINION OF LOEB & LOEB LLP RE LEGALITY d268585dex51.htm EX-5.1 11887
3 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO., LLP d268585dex231.htm EX-23.1 1733
4 GRAPHIC g268585g75v32.jpg GRAPHIC 3939
5 GRAPHIC g268585g97r88.jpg GRAPHIC 11222
  Complete submission text file 0001193125-11-347997.txt   218718
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-178656 | Film No.: 111273352
SIC: 2836 Biological Products, (No Diagnostic Substances)